| Human MART-1 (HLA-A*02:01) Tetramer Protein (LTP10027) |
| LTP10027 |
| 100ug |
|
$1350 In stock |
| Melanoma antigen recognized by T cell-1 (Mart-1), one of the melanosome-specific proteins, also recognized by cytotoxicity T lymphocytes as a marker. Mart-1 is considered to play a critical role in the immunotherapy for melanoma. |
| Recombinant Human MART-1 (HLA-A*02:01) Tetramer Protein is expressed from Expi293 with His tag and Avi tag at the C-terminal, tetramer is assembled by biotinylated monomer and streptavidin. It contains Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M) and ELAGIGILTV peptide. |
| MART-1 (HLA-A*02:01) Tetramer |
| Human |
| A0A140T913(HLA-A*02:01)&P61769(B2M)&ELAGIGILTV |
| Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M)and ELAGIGILTV peptide |
| The protein has a predicted MW of 258 kDa. Due to glycosylation, the protein migrates to 260-265 kDa under Non reducing (N) condition based on the Tris-Bis PAGE result. |
| 0 |
| C-His-Avi |
| Expi293 |
| > 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC |
| Less than 1EU per ug by the LAL method. |
| Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as a protectant before lyophilization. |
| Reconstituted protein stable at -80 C for 12 months, 4 C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
| Shipped at ambient temperature. |
| Centrifuge tubes before opening. Reconstituting to a concentration of more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water. |
| ![Human MART-1 (HLA-A*02:01) Tetramer Protein (LTP10027)](/peptide-product/images/protein-products/LTP10027/20220823103731.png) |